<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
      <journal-title>BMC Infectious Diseases</journal-title>
      <issn pub-type="epub">1471-2334</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16176580</article-id>
      <article-id pub-id-type="pmc">1262717</article-id>
      <article-id pub-id-type="publisher-id">1471-2334-5-74</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2334-5-74</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Leprosy &amp; gangrene: A rare association; role of anti phospholipid antibodies</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Akerkar</surname>
            <given-names>Shashank M</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shashank77_2000@yahoo.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Bichile</surname>
            <given-names>Lata S</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>lsbichile@rediffmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Lecturer, Rheumatology,Dept of Medicine,Seth GSMC &amp; KEM Hospital, Parel, Mumbai, India &#x2013; 400012</aff>
      <aff id="I2"><label>2</label>Chief Rheumatology,Head Dept of Medicine,Seth GSMC &amp; KEM Hospital, Parel, Mumbai, India &#x2013; 400012</aff>
      <pub-date pub-type="collection">
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>9</month>
        <year>2005</year>
      </pub-date>
      <volume>5</volume>
      <fpage>74</fpage>
      <lpage>74</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/74"/>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>4</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>21</day>
          <month>9</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2005 Akerkar and Bichile; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2005</copyright-year>
        <copyright-holder>Akerkar and Bichile; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Akerkar
               M
               Shashank
               
               shashank77_2000@yahoo.com
            </dc:author><dc:title>
            Leprosy &#x00026; gangrene: A rare association; role of anti phospholipid antibodies
         </dc:title><dc:date>2005</dc:date><dcterms:bibliographicCitation>BMC Infectious Diseases 5(1): 74-. (2005)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2334(2005)5:1&#x0003c;74&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2334</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Leprosy still remains an important public health problem for many parts of the world. An association of gangrene with leprosy is a rare one &amp; can have a number of causative mechanisms. We present a case with Leprosy &amp; gangrene with positive anti phopholipid antibody titers.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 50-year-old non-diabetic, non-hypertensive lady presented with 2 months history of progressive gangrene of bilateral toes. She was found to have madarosis &amp; hypopigmented, hypoaesthetic macular lesions on the upper limb &amp; thighs. Bilateral ulnar &amp; popliteal nerves were thickened. A skin biopsy of the lesions revealed borderline tuberculoid leprosy, slit skin smears revealed a bacteriological index of 1+. She did not have any evidence of thromboembolic episode or atherosclerosis. ACLA was positive at presentation &amp; also on another occasion 6 weeks later. ACLAs were of the IgM type on both occasions. Lupus Anticoagulant &amp; &#x3B2;2 GPI antibody were negative. DOPPLER of the lower limb arteries did not reveal any abnormality. Patient was successfully treated with multi-drug antileprotics &amp; anticoagulants.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Infectious APLAs should be recognized as a cause of thrombosis in Leprosy. Appropriate anticoagulation can salvage limb function.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Leprosy still remains an important public health problem for many parts of the world. An association of gangrene with leprosy is a rare one &amp; can have a number of causative mechanisms. We present a case with Leprosy &amp; gangrene with positive anti phopholipid antibody titers.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 50-year-old non-diabetic, non-hypertensive lady presented with 2 months history of progressive blackish discoloration of the toes bilaterally. Examination revealed gangrene of the Right great toe, 2<sup>nd </sup>toe &amp; early gangrenous changes in the 3<sup>rd </sup>toe. All the peripheral arteries were well felt, there was no radiofemoral delay. There was no cardiac murmur or a carotid bruit.</p>
      <p>She was found to have madarosis &amp; hypopigmented, hypoaesthetic macular lesions on the upper limb &amp; thighs. Bilateral ulnar &amp; popliteal nerves were thickened. A skin biopsy of the lesions revealed borderline tuberculoid leprosy. Slit skin smears revealed a bacteriological index of 1+. Erythrocyte sedimentation rate was 105, lipid profile &amp; fasting sugars were normal &amp; anti neutrophil cytoplsmic antibody (ANCA) negative.</p>
      <p>Anti Cardiolipin antibody (ACLA) was positive at presentation (IgG-8; IgM-28.5; ELISA Genesis Diagnostics, Cambridgeshire, UK) &amp; also on another occasion 6 weeks later (IgG-7.5; IgM-29; ELISA Genesis Diagnostics, Cambridgeshire, UK). Thus, ACLAs were of the IgM type on both occasions. Lupus Anticoagulant (PT, aPPT, Mixing studies, DRVVT) &amp; &#x3B2;2 GPI antibody were negative (IgG-1; IgM-2.5; ELISA Genesis Diagnostics, Cambridgeshire, UK). DOPPLER of the lower limb arteries did not reveal any abnormality. Tests for other hypercoagulable states (protein C, protein S, Antithrombin III, homocystein, factor V Leiden) were normal.</p>
      <p>The patient improved with the multi drug anti leprotics &amp; anticoagulants. By 6 weeks, there was no progression of/ fresh gangrene &amp; the pre gangrenous changes in the 3<sup>rd </sup>toe had resolved.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Antiphospholipid antibodies (APLA) are a group of autoantibodies, which have been reported in Antiphospholipid syndrome (APS), which is characterized by raised levels of ACLA, thrombosis, recurrent fetal loss &amp; thrombocytopenia. APLA is a generic term that describes closely related but not identical autoantibodies found in APS: ACLA, anti &#x3B2;2 GPI &amp; those with lupus anticoagulant activity. The syndrome can occur in its primary form or secondarily in association with other autoimmune disorders. Although raised levels of these antibodies were first reported only in autoimmune diseases, their prevalence is now known to be more widespread. Elevated levels of these antibodies have been found in various infections like Syphillis, HIV disease, HCV disease, tuberculosis, cytomegalovirus infection [<xref ref-type="bibr" rid="B1">1</xref>]. Loizou et al studied 112 leprosy patients &amp; found elevated titers of APLA in 29%, anti &#x3B2;2 GPI in 89%, &amp; anti-Prothrombin in 21% of them [<xref ref-type="bibr" rid="B2">2</xref>]. Initially, it seemed that infection induced APLA are not associated with the thrombotic manifestations of APS. This was attributed to the fact that the binding of autoimmune APLA to phospholipid is enhanced by the cofactor &#x3B2;2 GPI (i.e. &#x3B2;2 GPI dependent) while the binding of infection induced APLA is not enhanced by this cofactor (i.e. &#x3B2;2 GPI independent). Recent studies, however show that the APLA in leprosy patients are heterogeneous with respect to their &#x3B2;2 GPI requirement: in 10 of 31 leprosy sera, the APLA were &#x3B2;2 GPI dependent &amp; 16 of 31 were &#x3B2;2 GPI independent [<xref ref-type="bibr" rid="B3">3</xref>]. The clinical implications of this &#x3B2;2 GPI dependency are seen in Lucio's phenomenon in which the histopathological findings are related to microvascular thrombosis in the absence of inflammatory infiltration of the vessel wall. The &#x3B2;2 GPI dependency of APLA in this condition has been confirmed by Levi et al [<xref ref-type="bibr" rid="B4">4</xref>]. Apart from this evidence of microscopic thrombosis, frank gangrene in association with leprosy is a rare entity. It has been hypothesized that certain infections in genetically predisposed individuals may induce these APLA. Phospholipid binding peptides of bacterial &amp; viral origin that have structural similarity to the phospholipid sites have been detected &amp; found to induce APLA with properties similar to autoimmune APL in mice [<xref ref-type="bibr" rid="B5">5</xref>]. The elevated levels of IgM subtype of APLA seen in our patient is in accordance with other studies of APLA in leprosy [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>Gangrene of the extremities in leprosy can have mechanisms other than APLA alone. Vascular changes in the form of intimal thickening &amp; medial infiltration are known to occur in leprosy. Embolisation &amp; resultant grafting of the Virchow cells has been found to lead to obstruction of the vessels [<xref ref-type="bibr" rid="B8">8</xref>]. Four such cases of arterial obstruction have been described; 2 of them being occlusion of the posterior tibial artery by lepromatous infiltration [<xref ref-type="bibr" rid="B9">9</xref>]. Arteriographic abnormalities such as occlusion, narrowing, tortuosity, dilatation, poststenotic dilatation, irregularity and incomplete filling of the lumen have been found in the digital circulation in more than 75&#x2013;94% of leprosy patients [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>Nerve trunk hypertrophy secondary to lepromatous process can lead to arterial entrapment in the osteoligamentous channels. This entrapment as well as the irritation of sympathetic fibers can lead to spasm of the vessels &amp; resultant vascular compromise to the distal extremity. This has been confirmed with angiography &amp; reversal of the spasm as well as the vascular compromise seen after release of the roof of the osteoligamentous channel [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Our patient did not have any clinical or laboratory markers of atherosclerosis or embolism, DOPPLER of the lower limbs did not reveal any vascular obstruction involving the medium size arteries. In the absence of any other hypercoagulable states, APLA remains the most probable cause of the digital gangrene.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Infectious APLA should be recognized as a cause of thrombosis in Leprosy. Appropriate anticoagulation can salvage limb function. However, other mechanisms of gangrene need careful evaluation &amp; appropriate management.</p>
    </sec>
    <sec>
      <title>List of abbreviations</title>
      <p>APLA &#x2013; anti phospholipid antibody</p>
      <p>ACLA &#x2013; anti cardiolipin antibody</p>
      <p>&#x3B2;2 GPI &#x2013; &#x3B2;2 Glycoprotein I</p>
      <p>ANCA &#x2013; Anti Neutrophil Cytoplasmic Antibody</p>
      <p>APS &#x2013; Anti Phospholipid Syndrome</p>
      <p>PT &#x2013; Prothrombin Time</p>
      <p>aPPT &#x2013; Activated Partial Thromboplastin Time</p>
      <p>DRVVT &#x2013; Dilute Russel's Viper Venom Time</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>SA &amp; LB carried out the study and conceived of the study. SA drafted the manuscript &amp; LB reviewed the same. Both authors read and approved the final manuscript.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Gangrenous changes.</p>
        </caption>
        <graphic xlink:href="1471-2334-5-74-1"/>
      </fig>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/5/74/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>Written consent was obtained from the patient for the clinical photograph as well as publication of study.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roubey</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Immunology of the antiphospholipid antibody syndrome</article-title>
          <source>Arthritis Rheum</source>
          <year>1996</year>
          <volume>39</volume>
          <fpage>1444</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">8814055</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loizou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wypkema</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wypkema</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Asherson</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Anticardiolipin, anti-&#x3B2;<sub>2</sub>-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease</article-title>
          <source>Ann Rhem Dis</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>1106</fpage>
          <lpage>1111</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.62.11.1106</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hojnik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gilburd</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ziporen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Blank</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tomer</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Scheinberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tincani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rozman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Shoenfeld</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Anticardiolipin Antibodies in infections are heterogeneous in their dependency on &#x3B2;2 GPI : Analysis of anticardiolipin antibodies in leprosy</article-title>
          <source>Lupus</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>515</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="pmid">7704010</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Pierangeli</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Espinola</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Antiphospholipid beta-2 glycoprotein 1 dependency assay to determine antibody pathogenicity</article-title>
          <source>Arthritis Rheum</source>
          <year>2000</year>
          <volume>43</volume>
          <fpage>1476</fpage>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gharavi</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Chaimovich</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cucucrull</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Celli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gharavi</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Induction of Antiphospholipid antibodies by immunization with synthetic bacterial &amp; viral peptides</article-title>
          <source>Lupus</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>449</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">10483013</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Larranaga</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Forastiero</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Martinuzzo</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Carreras</surname>
              <given-names>LO</given-names>
            </name>
            <name>
              <surname>Tsariktsian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sturno</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity</article-title>
          <source>Lupus</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>594</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">11035434</pub-id>
          <pub-id pub-id-type="doi">10.1191/096120300678828712</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panunto-Castelo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Rosa</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Roque-Barreira</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The Rubino test for leprosy is a beta2-glycoprotein 1-dependent antiphospholipid reaction</article-title>
          <source>Immunology</source>
          <year>2000</year>
          <volume>101</volume>
          <fpage>147</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">11012766</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1365-2567.2000.00081.x</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Carayon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dharmendra</surname>
              <given-names/>
            </name>
          </person-group>
          <article-title>Vascular changes in leprosy</article-title>
          <source>Textbook of Leprosy</source>
          <year>1985</year>
          <publisher-name>Samant &amp; company</publisher-name>
          <fpage>853</fpage>
          <lpage>871</lpage>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Carayon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Camain</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Confrontation de 18 histologiede la clinique et de l'angiographie d'une multi nevrite tuberculoide reactionnelle</article-title>
          <source>Bull Soc Med Afr Noire Lgue Frse</source>
          <volume>XI</volume>
          <fpage>273</fpage>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wahi</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Chakravarti</surname>
              <given-names>RN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Peripheral vascular deficit in leprosy</article-title>
          <source>Int J Lepr Other Mycobact Dis</source>
          <year>1976</year>
          <volume>44</volume>
          <fpage>332</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">987995</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
